OncoCyte Corp (OCX)

[Tim501]

I own BTX, AST, and most recently OCX. I have owned BTX since it was BTIM trading below a buck. I think the latter two and therefore the "mothership" are going to do well over the coming years. As you likely know, all three have done fairly large cash raises in recent weeks, and each seem to be on the verge of rapidly ramping revenues as early as 2017. It has taken quite a while to get here. The data from AST (48% owned by BTX) this week was nothing short of astounding and that is a platform drug opportunity. With OCX, the data seems already conclusive for their lung cancer test, so we just have to await verification and then product ramp. Seems like everybody will want to use this new technology given current invasive and uncertainty issues with current standard of care.

Tim